Malignancies in blood-forming organs following diagnostic and therapeutic procedures: a review.
Ionizing radiation used for diagnosis or therapy has been associated with an increased incidence of malignancies of blood-forming organs. The increased incidence of hematopoietic malignancies following exposure to ionizing radiation obtained in the course of occupation, diagnosis and therapy of disease, or as a weapon of war is documented. The natural occurrence and the induced progression to acute leukemia of polycythemia rubra vera, Hodgkin's disease, multiple myeloma, Di Guglielmo's disease, and reticuloendothelial malignancies are discussed. The status of transplantation and immunodeficiency states and their relationship to acute leukemia is reviewed. Finally, drugs, toxins, and the use of cytotoxic radiomimetic agents for nonmalignant purposes are shown to lead to the development of acute leukemia. Background information relevant to the  proper use of future diagnostic and therapeutic modalities is provided.
D000208:Acute Disease; D002274:Carcinogens, Environmental; D006413:Hematopoietic System / Q000187:drug effects* / Q000528:radiation effects*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007938:Leukemia / Q000209:etiology*; D004915:Leukemia, Erythroblastic, Acute / Q000209:etiology; D007951:Leukemia, Myeloid / Q000209:etiology; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D009784:Occupational Diseases / Q000209:etiology; D011832:Radiation Injuries / Q000209:etiology; D011836:Radiation Tolerance; D011879:Radiotherapy Dosage; D012306:Risk
D002274:Carcinogens, Environmental